BioCentury
ARTICLE | Company News

Valeant selling Dendreon to Chinese conglomerate

January 10, 2017 11:58 PM UTC

Valeant Pharmaceuticals International Inc. (TSX:VRX; NYSE:VRX) is selling cancer company Dendreon Pharmaceuticals Inc. to Sanpower Group Co. Ltd. (Nanjing, China) for $819.9 million in cash. Valeant expects the deal to close this half...